Untitled - why apasl stc 2016?

Transcription

Untitled - why apasl stc 2016?
1
TENTATIVE COURSE PROGRAMME
22 September 2016
Murat ALADAG
Ahmet GURAKAR
A. Kadir DOKMECI
VIRAL HEPATITIS:
IMMUNEPATHOGENESIS,
DIAGNOSIS AND
MANAGEMENT
Halis SIMSEK
Ramazan IDILMAN
HALL C
COURSE - 3
APASL SINGLE
TOPIC LIVER
TRANSPLANTATION
COURSE
HALL B
COURSE - 2
COURSE - 1
HALL A
APASL - SINGLE
TOPIC ENDOSCOPY
COURSE
Emrah ALPER
SESSION 1:
SESSION 1:
SESSION 1:
Münci KALAYOGLU
Meral AKDOGAN
Murat Taner GULSEN
Gyongyi SZABO
Halis SİMSEK
Ramazan IDILMAN
Reşit MISTIK
Hitoshi MARUYAMA
Sadettin HULAGU
İbrahim Halil
BAHCECIOGLU
13:00
13:20
Patient Selection and
Preparation for Liver
Transplantation
Meral AKDOGAN
13:00
13:20
Immunity and
Inflammation in Chronic
HCV Infection
Gyongyi SZABO
13:00
13:20
Endoscopic
Management of
Eosophageal Varices
Abdurrahman
KADAYIFCI
13:20
13:40
Living Donor Liver
Transplantation in Portal
Vein Trombosis
Sezai YILMAZ
13:20
13:40
Non-invasive
Assessment of Liver
Fibrosis
Levent DOGANAY
13:20
13:40
Endoscopic
Management of
Gastric Varices
Hiroshi
YATSUHASHI
13:40
14:00
LDLT or DDLT in Acute
Fulminant Liver Failure
Cüneyt KAYAALP
13:40
14:00
Histopathological
Diagnosis of Chronic
Hepatitis B and C
Cenk SOKMENSUER
13:40
14:00
Therapy of Portal
Cholangiopathy
Hitoshi MARUYAMA
14:00
14:20
LDLT or DDLT in
Hepatocellular
Carcinoma
Deniz BALCI
14:00
14:20
New Imaging Modalities
for the Diagnosis of
Liver Diseases
Suna OZHAN OKTAR
14:00
14:20
TIPS: Indication,
Contraindication the
Impact of TIPS for
Portal Hypertension
Ahmet Baran ÖNAL
14:20
14:40
Coffee Break
9
TENTATIVE COURSE PROGRAMME
22 September 2016
HALL A
HALL B
HALL C
SESSION 2:
SESSION 2: TREATMENT OF
CHRONIC HEPATITIS B
SESSION 2: MANAGEMENT
OF BILIARY DISEASES
Yalçın POLAT
Murat ALADAG
Murat KIYICI
Gamal SHIHA
Hasan OZKAN
Osman Cavit OZDOGAN
Fehmi TABAK
Toshio TSUYUGUCHI
Billur CANBAKAN
Cemil SAVAS
Ahmet Faruk AGAN
14:40
15:00
Immunsupression in
Liver Transplantation
Wasim JAFRI
15:00
15:20
Pre-post Transplantation
15:00
HBV Treatment
15:20
Ramazan IDILMAN
14:40
15:00
Drug Targets on Viral
Replication in the New
Insight
Gyongyi SZABO
HBeAg (+) CHB: Treat
with IFN or with Nas
Jia-Horng KAO
14:40
15:00
Endoscopic
Approaches in
Primary Sclerosing
Cholangitis
Orhan TARCIN
15:00
15:20
Endoscopic
Treatment of Biliary
Strictures After Liver
Transplantation
Yaşar TUNA
15:20
15:40
Management of HCV in
Developing Countries
Hakan LEBLEBICIOGLU
15:20
15:40
HBeAg (-) CHB: Treat
with IFN or with Nas
Dinç DINCER
15:20
15:40
Endoscopic
Treatment of
Metastatic
Cholestatic Liver
Disease
Toshio TSUYUGUCHI
15:40
16:00
HCC: Resection or Liver
Transplantation
Chul Soo AHN
15:40
16:00
HBeAg (-) CHB: Therapy
and Stopping Rules
Lai WEI
15:40
16:00
Percutaneous
Treatment for
Malingnant Strictures
Murat KEKILLI
16:00
16:20
Discussion
16:00
16:20
Discussion
16:00
16:20
Discussion
16:20
16:40
10
Coffee Break
TENTATIVE COURSE PROGRAMME
22 September 2016
HALL A
HALL B
HALL C
SESSION 3:
SESSION 3: TREATMENT OF
CHRONIC HEAPTITIS C
SESSION 3:
ENDOSONOGRAPHY IN
HEPATOBILIARY DISEASES
Vivek KUMBHARI
Ali Emre TUZUN
Bülent ODEMIS
Kadir AKSOZ
Masao OMATA
Bülent YILDIRIM
Şükran KOSE
Can GONEN
Emrah ALPER
Ahmet BEKTAS
Cem KALAYCI
16:40
17:00
Post Transplant Bile
Duct Problems
Vivek KUMBHARI
16:40
17:00
Drugs for the Treatment
of HCV: Classification,
Sites of Action
Ayşe AYTAMAN
16:40
17:00
Efficacy of EUS in
Liver Diseases
Sinan AKAY
17:00
17:20
Diagnosis and
Palliative Treatment
in Cholangiocarcinomas
Deniz GUNEY
DUMAN
17:00
17:20
Post Transplant ERCP in
Difficult Cases
Murat HARPUTOGLU
17:00
17:20
Treatment of HCV in
the Real Word: Optimal
Regimes to Offer Within
the Cascade Approach
Nurdan TOZUN
17:20
17:40
Post Transplant PTC
Ramazan KUTLU
17:20
17:40
The Treatment of HCV,
Genotype 3
Saeed HAMID
17:20
17:40
What is the Role of
EUS in the Treatment
of Gallstones
Emrah ALPER
17:40
18:00
Prediction of Acute and
the Chronic Rejection of
Tranplanted Liver
Murat AKYILDIZ
17:40
18:00
The Treatment of
Genotype 4, 5 and 6
Alaa IBRAHIM
17:40
18:00
New Horizons in EUS
Hakan SENTUK
18:00
18:20
Discussion
18:00
18:20
Discussion
18:00
18:20
Discussion
Osman YÜKSEL
Sebnem GURSOY
18:20
18:40
18:20
18:40
Can We Stop Nas in
Patients with Chronic
Hepatitis B?
Alper YURCI
18:20
18:40
Where are We Now
in Cholangioscopy?
Toshio
TSUYUGUCHI
18:40
18:50
Discussion
18:40
18:50
Discussion
18:40
18:50
Discussion
11
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
HALL C
CHRONIC VIRAL HEPATITIS
METABOLIC LIVER DISEASE IN
THE PEDIATRIC PATIENTS
AUTOIMMUNE
HETATITIS
Jia- Horng KAO
Hikmet AKKIZ
Yusuf UZUN
Georgios LOUDIANOS
Aydan KANSU
Buket DALGIC
Çiğdem ARIKAN
Joest DRENTS
Erol AVSAR
Ömer TOPALAK
Ender ELLIDOKUZ
08:30
08:50
Why Non-Responder?
(Definition)
Jia-Horng KAO
08:30
08:50
Is it Increasing or Are
We Doing a Better Job?
Fatih EZGU
08:30
08:50
How to Diagnose
the Primary Biliary
Cirrhosis
Mehmet YALNIZ
08:50
09:10
What's the Molecular
Mechanism of
Non-Response?
Gyongi SZABO
08:50
09:10
New Insight of Wilson
Disease
Georgios LOUDIANOS
08:50
09:10
Primary Biliary
Cirrhosis Treatment;
Beyond UDCA
Mevlut BASKOL
09:10
09:30
Prediction and
Diagnose of
Non-Response?
Shahab ABID
09:10
09:30
Alpha-1 Antitrypsin
Deficiency
Nedim HADZIC
09:10
09:30
How to Diagnose of
Primary Sclerosing
Cholangitis
Ebubekir SENATES
09:30
09:50
Epidemiology and
Burden of
Non-Response in the
World
Simten MALHAN
09:30
09:50
Liver Storage Diseases
Figen GURAKAN
09:30
09:50
Treatment of Primary
Biliary Cirrhosis.
What is New in the
World?
Cumhur DULGER
09:50
10:00
Discussion
09:50
10:00
Discussion
09:50
10:00
Discussion
10:00
10:30
Coffee Break
13
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
HALL C
CHRONIC
HEPATITIS B
NASH
FREE
PAPERS
Wasim JAFRI
Abdullah SONSUZ
Yücel USTUNDAG
Salih HOSOGLU
Zaigam ABBAS
Rauf AGAYEV
Ömer SENTURK
Murat KEKILLI
Hakan LEBLEBICIOGLU
Hakan DURSUN
Mustafa SUNBUL
Elife ERARSLAN
10:30
10:50
The Impact of
Non-Response On The
Management of Chronic
Hbv Infection
Hikmet AKKIZ
10:30
10:50
Definition of
Non-Response in NASH.
Zaigam ABBAS
10:30
10:50
10:50
11:10
What Kind of Options
Do We Have? (Current
Management)
Saeed HAMID
10:50
11:10
Two "Atypical" Forms of
Nonalcoholic Fatty Liver
Disease: NAFLD Without
Metabolic Syndrome
and Lean NAFLD
Yusuf YILMAZ
10:50
11:10
11:10
11:30
New Horizons For The
Treatment Of Chronic
Hepatitis B
George LAU
11:10
11:30
NAFLD in Non Obese
People
Metin BASARANOGLU
11:10
11:30
11:30
11:50
Hbe Ag
Non-Seroconverter On
Long Term Anti Viral
Therapy
Deepak AMARAPURKAR
11:30
11:50
How to Treat NAFLD
Ahmet UYGUN
11:30
11:50
11:50
12:00
Discussion
11:50
12:00
Discussion
11:50
12:00
12:00
12:30
Opening Ceremony
12:30
13:00
A.Kadir DOKMECI
13:00
14:00
14
ART LECTURE
The Impact of RAV on The Treatment of Chronic Hepatitis C Masao OMATA
GILEAD SATELLITE SYMPOSIUM & LUNCH
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
HALL C
CHRONIC
HEPATITIS D
THE CHALLENGES IN HEPATATIC
VASCULARY DISEASES
AUTOIMMUNE HEPATIT,
HCC AND BLEEDING
Mario RIZETTO
Halil DEGERTEKIN
Yıldıran SONGUR
Mustafa Kemal CELEN
Jose SOLLANO
Emin ALTIPARMAK
Hakkı POLAT
Hasmik GHAZINYAN
Mehmet YUCESOY
Enver DOLAR
Mehmet SOKMEN
Hüseyin ATASEVEN
14:00
14:20
Retreatment With
Interferon In Non
Responders.
Fulya GUNSAR
14:00
14:20
Difficulties in Treatment
of Budd Chiari Disease
Jose SOLLANO
14:00
14:20
Steroid Refractory
Autoimmune
Hepatitis
Goktug SIRIN
14:20
14:40
Longer Treatment With
14:20
Interferon As An Option.
14:40
Cihan YURDAYDIN
Therapeutic Decision in
Portal Vein Thrombosis
Vedat GORAL
14:20
14:40
Autoimmune
Hepatitis: Treatment
and Outcomes
Ian Homer Y. CUA
14:40
15:00
Bridging And
Downstaging
Treatments in
Patients On the
Waiting List For
Transplantation
Sadık BILGIC
14:40
15:00
The Treatment of
Hepatic Sinusoidal
Obstruction Syndrome.
Alpaslan TANOGLU
15:00
15:20
New Treatment
Modalities In
Non-Responders
Mario RIZETTO
15:00
15:20
Interventional Radiology
in Hepatic Vasculary
Diseases
Sadık BILGIC
15:00
15:20
Interventional
Endoscopic
Examination in Liver
Cirrhosis
Fatih ASLAN
15:20
15:30
Discussion
15:20
15:30
Discussion
15:20
15:30
Discussion
14:40
15:00
The Treatment Of
Co-Infection With Delta
Reşat OZARAS
15:30
16:00
Coffee Break
16:00
17:00
ABBVIE SATELLITE SYMPOSIUM
15
TENTATIVE CONGRESS PROGRAMME
23 September 2016
HALL A
HALL B
SPECIAL POPULATIONS
IN CHB
ALCOHOLIC LIVER
DISEASES
Tarık ASSELAH
M. Hadi YASA
Kendal YALCIN
Gülbanu CANBALOGLU ERKAN
Rino GANI
Ayşegül OZAKYOL
Yaşar NAZLIGUL
Fatih ALBAYRAK
HALL C
HCV
Belkıs UNSAL
İsmail BALIK
Bilgehan AYGEN
Neşe IMERYUZ
17:00
17:20
Pregnancy and
Lactation
Nevin YILMAZ
17:00
17:20
What To Do in
Non-Responders
Of Acute Alcoholic
Hepatitis
Dong Joon KIM
17:00
17:20
Non Response
During DAAs Era
Lai WEI
17:20
17:40
Immunocompromised
Patients
Bülent DEGERTEKIN
17:20
17:40
Treatment For Chronic
Alcoholic Cholestatic
Disease
Yusuf YAZGAN
17:20
17:40
The Treatment of
HCV in Special
Populations
Necati ORMECI
17:40
18:00
Factors Associated
With
Non-Responders of
Hepatitis B,C and
Delta, in Pakistan.
Shahab ABID
17:40
18:00
Chronic Renal Failure
Tevfik ECDER
17:40
18:00
Challenges In Liver
Transplantation of
Alcoholic Cirrhosis
Diana A. PAYAWAL
18:00
18:20
Co-infection
Tarık ASSELAH
18:00
18:20
Imaging and New
Treatment Modality of
HCC (CCC)
Shuichiro SHIINA
18:00
18:20
The Treatments With
Inhibitors of Cell
Entrance in Chronic
HCV Infection
Che COLPITTS
18:20
18:30
Discussion
18:20
18:30
Discussion
18:20
18:30
Discussion
Mohammed Hossein SOMI
18:30
18:50
16
A Novel Immune
Therapy for Chronic
Hepatitis B: Relevance
to Reduction of NonResponder of Present
Therapeutic Options
Fazle AKBAR
Enver ZEREM
18:30
18:50
18:30
18:50
Hepathopulmonary
and
Porthopulmonary
Syndromes,
Diagnoses and
Treatments
Ahmet GURAKAR
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
CHRONIC
HEPATITIS C
HCC
FREE
PAPERS
Tarık ASSELAH
Necati ORMECI
İftihar KOKSAL
Macit GULTEN
Shuichiro SHIINA
Bülent KANTARCEKEN
Ömer SENTURK
Dursun Kadir BAHAR
Oidov BAATATKHUU
Necati YENICE
Fuat EKIZ
İlker TURAN
08:30
08:50
Primary Antiviral
Resistance; Is It Clinically
Important
Tarık ASSELAH
08:30
08:50
Best Treatment
Option in HCC;
Ablation, Resection
or Transplantation?
Shuichiro SHIINA
08:30
08:50
08:50
09:10
Current Treatment of
CHC in Terms of
Guide-lines
Ayşe AYTAMAN
08:50
09:10
Predictions of
Recurrence and
Prevention of
Recurrence, How?
Hikmet AKKIZ
08:50
09:10
09:10
09:30
Management of Direct
Acting Antivirals
Treatment Failure
Wasim JAFRI
09:10
09:30
Management of
Patients with Recurrent
Hepatocellular
Carcinoma
Salim DEMIRCI
09:10
09:30
09:30
09:50
The Situation of IFN
Free Treatment in
Chronic HCV
Osamu YOKOSUKA
09:30
09:50
When the Palliative
Chemotherapy is an
Option?
Şuayib YALCIN
09:30
09:50
09:50
10:00
Discussion
09:50
10:00
Discussion
09:50
10:00
10:00
10:30
18
Coffee Break
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
ACUTE ON CHRONIC LIVER
FAILURE
AUTOIMMUNE LIVER
DISEASES
FREE
PAPERS
Shiv SARIN
Sabahattin KAYMAKOGLU
Mehmet IBIS
Osman YUKSEL
Joest DRENTS
Sait BAGCI
Cemil SAVAS
Nihat OKCU
Salimur RAHMAN
Metin UZMAN
Beytullah YILDIRIM
Birol BAYSAL
10:30
10:50
Definition of ACLF
A.Kadir DOKMECI
10:30
10:50
Treatment of
Autoimmune Hepatitis
Together with Chronic
HBV or HCV
Joest DRENTS
10:50
11:10
Acute Insult of ACLF
Mamun Al MAHTAB
10:50
11:10
The Treatment of Acute
Fulminant Autoimmune
Hepatitis
Gamal SHIHA
10:50
11:10
11:10
11:30
Acute Kidney Injury in
ACLF
Yogesh CHAWLA
11:10
11:30
The treatment of
Autoimmune Liver
Cirrhosis
Ahmet GURAKAR
11:10
11:30
11:30
11:50
Therapy of ACLF
Shiv SARIN
11:30
11:50
The Non-response in
Overlap and Outlier
Syndromes
Ömer OZBAKIR
11:30
11:50
11:50
12:00
Discussion
11:50
12:00
Discussion
11:50
12:00
10:30
10:50
Discussion
12:00
12:30
CONFERENCE:
Hasan OZKAN- Shiv SARIN
12:30
13:00
Okuda Lectures: Necati ORMECI Stemcell Transplantation: Stephen STROM
13:00
14:00
LUNCH & SATELLITE SYMPOSIUM
19
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
TRANSPLANTATION
NON-RESPONSE IN LIVERRELATED COMPLICATIONS
VIRAL HEPATITIS
B, C, D
Alaa IBRAHIM
Murat ALADAG
Mamun Al MAHTAB
Çetin KARACA
Barjesh C SHARMA
Mehmet ARSLAN
Filiz AKYUZ
Ali DEMIR
Shahab ABID
Celal ULASOGLU
Rahmet GUNER
Kenan HIZEL
14:00
14:20
Pre and Post Liver Tx
HBV Treatment ; HBIG
Prophylaxis
Tatsua KANDA
14:00
14:20
The Treatment of
HBV in Special
Populations
Meltem ERGUN
14:20
14:40
Management of
Cirrhotic Refracter
Ascitis
İnci SULEYMANLAR
14:20
14:40
The Treatment
of HBV in
Haematologic
Disorders
George LAU
14:40
15:00
Minimal Hepatic
Encephalopathy, Shoud
We treat or Not
Barjesh C SHARMA
14:40
15:00
Management of
HBV in Pregnancy
Yasemin BALABAN
15:00
15:20
Management of Pre
and Post Transplanted
Patients with Chronic
HCV Ahmet GURAKAR
15:00
15:20
Approach to Patient
with Resistant
Hyponatremia
Seyfettin KOKLU
15:00
15:20
The Clinical
Utility of HBsAg
Quantification in the
Natural Course of
Chronic Hepatitis B
Hasan OZKAN
15:20
15:30
Discussion
15:20
15:30
Discussion
15:20
15:30
Discussion
14:00
14:20
Management of
Cirrhotic Ascites
Mehmet ARHAN
14:20
14:40
Treatment of Rejection
in Patients with Steroid
Resistant
Chandan KUMAR
14:40
15:00
Biliary Complications in
Post-Transplant Patients
İrfan KORUK
15:30
16:00
Coffee Break
16:00
17:00
SATELLITE SYMPOSIUM
20
TENTATIVE CONGRESS PROGRAMME
24 September 2016
HALL A
HALL B
HALL C
PRESIDENT’S
CHOICES
CASE PRESENTATIONS
THE TREATMENT OF
CIRRHOSIS COMPLICATIONS
Nihat OKCU
Necla TULEK
Arif Mansur COSAR
Altuğ SENOL
M.Kürşat TURKDOGAN
Celal AYAZ
Ramazan KURT
Ahmet UYANIKOGLU
Kadri GUVEN
Cem KOCKAR
Ali Tüzün INCE
Hakan YUCEYAR
17:00
17:20
17:00
17:20
17:00
17:20
The Non-response
to Treatment
with Terlipressin
and Albumin
in Hepatorenal
Syndrome
Salimur RAHMAN
17:20
17:40
17:20
17:40
17:20
17:40
The Non-response to
Vasoactive Therapy
in Variceal Bleeding
Sahin COBAN
17:40
18:00
17:40
18:00
17:40
18:00
The Treatment of
Spontan Bacterial
Peritonitis
Hakan ERDEM
18:00
18:20
The Treatment of
Portal Hypertensive
Gastroenteropathy in
Liver Cirrhosis
Tuğrul PURNAK
18:20
18:30
Discussion
18:30
19:10
CONFERENCE:
How Can We Predict
Future About HCV
Homie RAZAVI
18:00
18:20
18:20
18:30
18:00
18:20
Discussion
18:20
18:30
Discussion
Laurentius A. LESMANA
18:30
19:10
CONFERENCE:
Acute Liver Failure How
to Treat
Ayse AYTAMAN
Wan-Long CHUANG
18:30
19:10
Diagnostic Approach
for Non-Alcoholic Fatty
Liver Disease
Amna Subhan BUTT
Laurentius A. LESMANA
Muammer KARA
21

Similar documents